• Chloroquine: From Mechanism to Assay Decisions

  2026-08-17

  Chloroquine is more than an autophagy inhibitor: its compartment-specific pharmacology shapes how researchers interpret malaria, immune, cancer, and antiviral assays. This guide translates mechanistic and clinical evidence into practical experimental decisions.

• Autophagy, Periostin, and Cementoblast Mineralization

  2026-08-17

  The reference study identifies autophagy as a functional mediator of cementoblast mineralization during compressive stress and connects this process to a periostin/β-catenin signaling axis. Its combined in vitro, transcriptomic, mechanistic, and mouse-model evidence provides a framework for studying orthodontic cementum damage and root-resorption repair.

• Reversine: Aurora Kinase Inhibitor Workflow

  2026-08-16

  Reversine (SKU A3760) provides a research tool for probing Aurora kinase activity, mitotic control, and associated changes in cancer-cell phenotypes. This guide covers preparation, assay controls, and interpretation limits; it should not be used to support clinical, diagnostic, or therapeutic conclusions.

• GSK-923295: A Precision Probe of Mitotic Fidelity

  2026-08-15

  GSK-923295 is a potent CENP-E inhibitor for dissecting chromosome alignment, mitotic arrest, and centromere-linked phenotypes. This article presents an assay framework that separates motor-dependent congression defects from broader centromere architecture failures described in CTCF-depletion studies.

• Amplex Red Maps Iron-Linked Airway Inflammation

  2026-08-14

  Amplex Red can add a quantitative hydrogen peroxide layer to studies of iron-driven GSDMD activation and allergic airway inflammation. This article explains how to use the probe as a mechanistic, not merely descriptive, readout of redox signaling while avoiding overinterpretation of localized Fenton chemistry.

• Bradykinin B2 Receptors and Ileal Peristalsis

  2026-08-14

  The reference study identified bradykinin B2 receptors as inhibitory modulators of the guinea pig isolated ileal peristaltic reflex, extending kinin pharmacology beyond direct smooth-muscle responses. Its pressure-threshold design and antagonist controls provide a useful framework for distinguishing receptor-specific effects on gastrointestinal propulsion from generalized tissue contraction or relaxation.

• Ceftazidime as a Phenotypic Resistance Probe

  2026-08-13

  Ceftazidime is a third-generation cephalosporin with valuable activity against Pseudomonas aeruginosa and other aerobic Gram-negative bacteria. This guide shows how to use its phenotype alongside gene, plasmid, and strain-typing data to interpret resistance transmission without overclaiming what any single assay proves.

• Trichostatin A (TSA): Applied Research Workflows

  2026-08-13

  Trichostatin A (TSA) provides a reversible way to connect histone hyperacetylation with cell-cycle control, differentiation, and cancer phenotypes. This guide translates its use into practical cell-based workflows while clarifying why TSA should not be treated as a selective SIRT1 probe in centrosome studies.

• Entecavir (BMS200475) in Chronic Hepatitis B

  2026-08-12

  Fabien Zoulim’s reference review presents Entecavir, also known as BMS200475, as a structurally distinctive guanosine analog that suppresses HBV reverse transcription more potently than several established nucleoside analogs. Its integrated evidence from biochemical, cell-based, animal, and clinical studies explains both its therapeutic value and the resistance risks that remain important in lamivudine-experienced patients.

• Pravastatin Sodium: Assay Workflows & Troubleshooting

  2026-08-12

  Build cleaner cholesterol, LDL, macrophage, and hepatocyte assays with Pravastatin sodium, a selective HMG-CoA reductase inhibitor. This guide combines dose planning, transporter-aware controls, and practical troubleshooting for reproducible bench workflows.

• Lyso-Tracker Red: Reading Lysosome Biology

  2026-08-11

  Lyso-Tracker Red supports lysosome labeling in live cells, but its greatest value lies in interpreting acidic-compartment behavior rather than simply producing red images. This article connects live-cell assay design with mechanistic insights from a nanozyme study of intramacrophage bacteria and CRC immunotherapy.

• 15-PGDH Inhibition Preserves Muscle During Semaglutide Loss

  2026-08-11

  The reference study identifies 15-PGDH inhibition as a strategy to improve muscle stem cell activity, regenerated myofiber growth, and strength recovery during semaglutide-associated weight loss. Its mouse data suggest that combining a 15-PGDH inhibitor with a GLP-1 receptor agonist can improve postinjury muscle quality without reducing the intended loss of body weight.

• Angiotensin II: Mechanism-First Assay Design

  2026-08-10

  Angiotensin II is more than a vasopressor model: it is a controllable probe for connecting receptor signaling with atrial DNA damage, autophagy, inflammation, and remodeling. This guide translates recent hypertension research into practical assay architecture, dosing decisions, and interpretation strategies.

• Phosphorylated NPY1R in Intracranial Aneurysm

  2026-08-09

  The December 2024 reference study identifies TK-mediated phosphorylation of NPY1R as a regulatory event connecting vascular smooth muscle cell phenotypic transition with inflammation and macrophage infiltration during intracranial aneurysm progression. Its combination of human tissue analysis, mouse modeling, molecular perturbation, and macrophage ablation provides a mechanistic framework for interpreting vascular remodeling and immune-cell interactions.

• Genotyping Kit for target alleles: Workflow

  2026-08-08

  Accelerate PCR-based allele screening across insects, tissues, fishes, and cultured cells with a single-tube DNA preparation workflow. K1026 combines rapid lysis, balancing chemistry, and a dye-containing 2× PCR Master Mix to reduce handling, cleanup, and contamination risk.

557 records 8/38 page Previous Next First page 上5页 678910 下5页 Last page